HUM's CenterWell venture with BlackRock brings $2.8 billion in capital, easing balance sheet liabilities and supporting clinic expansion.
Humana (HUM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Humana's 2027 Medicare Advantage ratings rebound puts 95% of members in four-star or better plans, potentially boosting 2028 bonus payments and plan benefits.
Humana surged after its main Medicare Advantage contract regained a 4-star CMS rating for 2027, a major profit catalyst. 95% of HUM's Medicare Advantage members will be in 4-star plans, unlocking a 5% benchmark rate advantage and supporting a robust earnings outlook. I maintain a "Hold" rating as shares appear fairly valued post-rally, despite strong fundamentals, a technical breakout, and likely further sell-side upgrades.
Humana shares are soaring after the health insurer said it received improved star ratings for a number of its Medicare Advantage plans.
Humana (NYSE:HUM) shares were up nearly 15% on Friday after the company improved its Medicare Advantage quality ratings for 2027. Around 95% of members enrolled in plans rated at least four stars, strengthening its position ahead of the annual enrollment period.
Better Medicare quality scores are reordering the managed care rankings, and shares of Humana (NYSE:HUM | HUM Price Prediction) are setting the pace.
Humana said 95% of its Medicare Advantage members are enrolled in plans rated at least four stars for 2027, an improvement that could make more of its membership eligible for quality-related bonus payments.
SpaceX stock is rising, while AT&T, Verizon, and T-Mobile shares are falling as investors fret Elon Musk's aerospace company will muscle into telecom.
Improving Medicare Advantage ratings isn't easy. Stars are based on 40-some criteria that encompass patient experience surveys and a range of care metrics.
Barclays just pulled Humana off its neutral bench and handed it a bold new target, sending shares soaring while the rest of managed care barely blinked.
Humana (HUM) reported earnings 30 days ago. What's next for the stock?